Molecular Biosciences can be viewed as a dynamic continuum in which approaches derived from chemistry, physics and biology address fundamental mechanisms of living things. The School of Molecular Biosciences offers exciting opportunities for students to explore a wide range of future career paths in the life sciences. More->
SMB Mission Statement and Strategic Goals SMB Bylaws Graduate Student Bylaws SMB Undergraduate Student Learning Outcomes
Congratulations to our 2014 summer graduates:
Dr. Tyson Eucker, Ph.D. in Molecular Biosciences successfully defended his dissertation entitled Campylobacter jejuni Manipulates the Focal Complex to Invade Epithelial Cells and Induce Secretion of Interleukin-8 and has been accepted a position at Boehringer-Ingelheim Vetmedica in Ames, IA.
Dr. Elizabeth (Lisa) Evans, Ph.D. in Molecular Biosciences successfully defended her dissertation entitled Investigating the Degradation of Retinoic Acid via Cytochrome P450 Enzymes, CYP26A1 and CYP26B1, in the Postnatal Testis and been accepted as a postdoc at the University of Texas – M.D. Anderson Cancer Center.
Congratulations to Regents Professor Michael Smerdon and Dr. Peng Mao, a postdoctoral researcher in his laboratory, for discovery of an early step in the process of repairing damaged DNA that has the potential to lead to new targets for the treatment of a number of human diseases including cancer. In a study published in this week’s Proceedings of the National Academy of Sciences, Drs. Smerdon and Mao identified a chromatin response to DNA damage-induced RNA polymerase II arrest (deubiquitylation of histone H2B), that helps 'fine-tune' the chromatin landscape to allow DNA repair enzymes access to damage in chromatin while avoiding excess RNAPII degradation. Modulation of this step in the repair process may eventually lead to more effective therapy for DNA repair-deficient diseases, such as Cockayne Syndrome, a disease that causes extreme sun sensitivity, nervous system degeneration and premature aging. For more information go to: https://news.wsu.edu/2014/08/18/wsu-researchers-find-crucial-step-in-dna-repair/#.U_ONBk3n_cs
Congratulations to Dr. Eric Shelden, Associate Professor in SMB, for his recent appointment to the Editorial Board of PLOS ONE. This Online journal was launched in December, 2006, as an efficient and economical venue for disseminating research in all areas of science and medicine. Today it is the largest journal in the world, publishing well over 2000 articles per month. PLOS ONE’s editorial criteria focuses on the technical quality of the work rather than any subjective judgments such as perceived novelty or limited relevance to a specialist field.
"Breaking Bad: Observing Polymerase-induced DNA Damage"
Dr. Bret Freudenthal
September 18, 2014
Life Sciences 402
presents the SMB Seminar: Cooperativity Between Id4 and Sox2 for Induction of Utf1 Expression Influences Maintenance of the Spermatogonial Stem Cell Pool
BLS 402 2:10 pm
"Untangling Membrane Rearrangement by the Nidoviralies: Lessons from SARS Coronavirus"
Dr. Michael Buchmeier
September 25, 2014
Life Sciences 402